MDLN - CIK 0002046386
The table below shows Medline Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 |
|---|---|---|
| Operating cash flow | $412.00M | $682.00M |
| Capital expenditure | $96.00M | $98.00M |
| Investing cash flow | -$96.00M | -$92.00M |
| Dividends paid | - | - |
| Stock buybacks | $0.00 | $9.00M |
| Financing cash flow | -$13.00M | -$9.00M |
Medline Inc. reported operating cash flow of $1.74B for fiscal year 2025. That is down 1.4% from $1.77B in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.